MedAdvisor Ltd

ASX:MDR (Australia)  
A$ 0.43 (-2.27%) Jun 21
At Loss
P/B:
4.22
Market Cap:
A$ 236.73M ($ 157.04M)
Enterprise V:
A$ 226.83M ($ 150.47M)
Volume:
58.65K
Avg Vol (2M):
929.44K
Trade In:
Volume:
58.65K
At Loss
Avg Vol (2M):
929.44K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for MedAdvisor Ltd ( ASX:MDR ) from 2011 to Jun 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. MedAdvisor stock (ASX:MDR) PE ratio as of Jun 24 2024 is 0. More Details

MedAdvisor Ltd (ASX:MDR) PE Ratio (TTM) Chart

To

MedAdvisor Ltd (ASX:MDR) PE Ratio (TTM) Historical Data

Total 1297
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
MedAdvisor PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-24 At Loss 2024-04-22 At Loss
2024-06-21 At Loss 2024-04-19 At Loss
2024-06-20 At Loss 2024-04-18 At Loss
2024-06-19 At Loss 2024-04-17 At Loss
2024-06-18 At Loss 2024-04-16 At Loss
2024-06-17 At Loss 2024-04-15 At Loss
2024-06-14 At Loss 2024-04-12 At Loss
2024-06-13 At Loss 2024-04-11 At Loss
2024-06-12 At Loss 2024-04-10 At Loss
2024-06-11 At Loss 2024-04-09 At Loss
2024-06-10 At Loss 2024-04-08 At Loss
2024-06-07 At Loss 2024-04-05 At Loss
2024-06-06 At Loss 2024-04-04 At Loss
2024-06-05 At Loss 2024-04-03 At Loss
2024-06-04 At Loss 2024-04-02 At Loss
2024-06-03 At Loss 2024-04-01 At Loss
2024-05-31 At Loss 2024-03-29 At Loss
2024-05-30 At Loss 2024-03-28 At Loss
2024-05-29 At Loss 2024-03-27 At Loss
2024-05-28 At Loss 2024-03-26 At Loss
2024-05-27 At Loss 2024-03-25 At Loss
2024-05-24 At Loss 2024-03-22 At Loss
2024-05-23 At Loss 2024-03-21 At Loss
2024-05-22 At Loss 2024-03-20 At Loss
2024-05-21 At Loss 2024-03-19 At Loss
2024-05-20 At Loss 2024-03-18 At Loss
2024-05-17 At Loss 2024-03-15 At Loss
2024-05-16 At Loss 2024-03-14 At Loss
2024-05-15 At Loss 2024-03-13 At Loss
2024-05-14 At Loss 2024-03-12 At Loss
2024-05-13 At Loss 2024-03-11 At Loss
2024-05-10 At Loss 2024-03-08 At Loss
2024-05-09 At Loss 2024-03-07 At Loss
2024-05-08 At Loss 2024-03-06 At Loss
2024-05-07 At Loss 2024-03-05 At Loss
2024-05-06 At Loss 2024-03-04 At Loss
2024-05-03 At Loss 2024-03-01 At Loss
2024-05-02 At Loss 2024-02-29 At Loss
2024-05-01 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss
2024-04-23 At Loss 2024-02-20 At Loss

MedAdvisor Ltd (ASX:MDR) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has five reporting segments: ANZ Operations, USA Operations, UK Operations, Asia Operations, and Corporate. The company derives majority of its revenues from AU Operations.